X-FLOW PROSTATECTOMY CATHETER
Report
- Report Number
- 9610711-2025-00017
- Event Type
- Malfunction
- Date Received
- January 23, 2025
- Date of Event
- December 26, 2024
- Report Date
- March 21, 2025
- Manufacturer
- COLOPLAST A/S
- Product Code
- EZL
- UDI-DI
- 03600040144183
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
AFTER RECEIVING THIS COMPLAINT, WE SEARCHED FOR OTHER COMPLAINTS AND WE DIDN'T FIND OTHER COMPLAINTS REGARDING THE LOT NUMBER 9143103 ON THE SAME DEFECT.
AFTER RECEIVING THIS COMPLAINT, WE SEARCHED FOR OTHER COMPLAINTS AND WE DIDN'T FIND OTHER COMPLAINT REGARDING THE LOT NUMBER 9143103 ON THE SAME DEFECT. BALLOONS COMPONENTS WERE MADE FROM 2 DIFFERENT BATCHES OF VS014150 (REFERENCE) AND THE LOT NUMBER WERE 8807787 & 8789748 IT WAS PREPARED FROM A MIX OF RAW MATERIALS SAA339 LOT NUMBER 2203150048 & 2209060067 & 2202080081 AND SA7117 LOT NUMBER 2205240137. THESE LOTS NUMBER WERE ANALYSED AT OUR QA PRODUCTION LABORATORIES AND WERE CONFORMED. WE RECEIVED ONE USED SAMPLE WITH BALLOON BURST. BALLOON WAS BURST, AND ONE PART OF THE BALLOON HAS COMPLETELY DETACHED FROM THE CATHETER DURING DISINFECTION. IN THIS CONDITION IT WAS DIFFICULT TO CHECK THE INTEGRITY OF THE BALLOON. BURSTING ISSUE OF SILICONE BALLOON IS KNOWN BUT ACCORDING TO THE AVAILABLE INFORMATION WE CANNOT CONCLUDE ON A SPECIFIC ROOT CAUSE IN THIS CASE. QUALITY DATABASE WAS CHECKED AND REVEALED A CORRECTIVE AND PREVENTIVE ACTION: CAPA-000152. "BALLOON ISSUES ON FOLYSIL AND SILICONE PROSTATIC CATHETERS" WAS OPENED AND MONTHLY MONITORING. NO CORRECTIVE ACTION WILL BE IMPLEMENTED AS OUR TREND IS NOT INCREASING AND THE THRESHOLD IS NOT EXCEEDED. A SIMILAR CASE STUDY WAS PERFORMED BASED ON PRODUCT PROSTATIC CATHETER, DEFECT BALLOON BURST FROM (B)(6) 2021 TO (B)(6) 2025: 121 SIMILAR CASES WERE FOUND. THE EVALUATION HAS SHOWED THAT RISKS ARE ADEQUATELY CONTROLLED AND REDUCED AS FAR AS POSSIBLE IN THE STATE OF ART LEVEL. BASED ON THIS, WE CAN CONCLUDE THAT RESIDUAL RISKS ARE ADEQUATELY CONTROLLED AND REDUCED AS FAR AS POSSIBLE, AND THE RESIDUAL RISKS ASSOCIATED WITH THE USE OF THE PRODUCT ARE ACCEPTABLE WHEN WEIGHED AGAINST THE BENEFITS TO THE PATIENT/USER. IT IS CONCLUDED THAT THE RISKS IDENTIFIED ARE STILL ACCEPTABLE AND CONSIDERED AS SAFE.
ACCORDING TO THE AVAILABLE INFORMATION, ON (B)(6), A BLADDER CATHETER WAS INSERTED AT THE END OF THE DAY. THE MORNING OF (B)(6), DURING THE NURSE'S ROUNDS, THE NURSE NOTICED URINE IN THE PATIENT'S BED. SHE FOUND THE CATHETER EXTERIORIZED AND THE BALLOON RUPTURED. THERE WERE NO CONSEQUENCES FOR THE PATIENT. THIS WAS AN ISOLATED INCIDENT.
ACCORDING TO THE AVAILABLE INFORMATION, ON (B)(6), A BLADDER CATHETER WAS INSERTED AT THE END OF THE DAY. THE MORNING OF (B)(6), DURING THE NURSE'S ROUNDS, THE NURSE NOTICED URINE IN THE PATIENT'S BED. SHE FOUND THE CATHETER EXTERIORIZED AND THE BALLOON RUPTURED. THERE WERE NO CONSEQUENCES FOR THE PATIENT. THIS WAS AN ISOLATED INCIDENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 525060 | X-FLOW PROSTATECTOMY CATHETER | INDWELLING URETHRAL DRAINAGE BALLOON CATHETER, NON-ANTIMICROBIAL | EZL | COLOPLAST A/S | 9143103_AB63181002 | 03600040144183 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |